Compare OBK & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | OPK |
|---|---|---|
| Founded | 1912 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 921.2M |
| IPO Year | 2018 | 2011 |
| Metric | OBK | OPK |
|---|---|---|
| Price | $47.72 | $1.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $46.67 | $1.60 |
| AVG Volume (30 Days) | 133.0K | ★ 2.5M |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $26.43 | N/A |
| Revenue Next Year | $5.79 | $4.24 |
| P/E Ratio | $53.09 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.13 | $0.98 |
| 52 Week High | $48.12 | $1.60 |
| Indicator | OBK | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 60.36 | 70.52 |
| Support Level | $45.06 | $1.28 |
| Resistance Level | $47.96 | $1.42 |
| Average True Range (ATR) | 0.99 | 0.04 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 86.87 | 93.33 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.